Basic Information
Basic information for MIR646HG-216-89aa
Peptide Name MIR646HG-216-89aa
Genome Position chr20:60100217-60100219,60117744-60117807,60121028-60121121,60138494-60138599[+]
Species Human
Peptide Sequence MFEIPNTISVEKTKKDSVFNSKGRSEILPHFFKRRAWNWPIRLFPRWITEQKGRCSQALPQFKDLTQRLSGPVVEGLRKNCCWWTGSGS
Peptide Length 89
Unique Yes
Grand Average of Hydropathicity -0.6449
Relative Molecular Mass 12025.51
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000653814;MIR646HG-216
Transcript Length 1086
Coding Ability 0.4254
DNA Sequence Corresponding to Peptide ATGTTTGAGATTCCAAATACGATTTCTGTGGAGAAAACAAAAAAGGACTCTGTTTTTAATTCAAAAGGGAGAAGTGAAATTCTACCTCACTTTTTTAAAAGAAGAGCCTGGAATTGGCCTATCCGTCTTTTTCCCCGTTGGATCACAGAGCAGAAAGGAAGATGCTCCCAGGCTCTCCCGCAGTTTAAAGACTTAACTCAGCGGCTTTCAGGGCCTGTGGTTGAGGGACTCCGAAAGAACTGTTGCTGGTGGACCGGTTCAGGGTCT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :